Paradigm Capital Management Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Hold
11,400
– – 0.01% 112
2026
Q1
$320K Hold
11,400
– – 0.01% 107
2025
Q4
$284K Hold
11,400
– – 0.01% 110
2025
Q3
$290K Hold
11,400
– – 0.01% 121
2025
Q2
$276K Sell
11,400
-5,600
-33% -$131K 0.01% 113
2025
Q1
$431K Hold
17,000
– – 0.02% 108
2024
Q4
$451K Hold
17,000
– – 0.02% 112
2024
Q3
$492K Hold
17,000
– – 0.02% 115
2024
Q2
$476K Hold
17,000
– – 0.02% 116
2024
Q1
$472K Buy
+17,000
New +$472K 0.02% 117

Other funds holding PFE

Paradigm Capital Management Inc's PFE Position: Q2 2026 in Review

Paradigm Capital Management Inc held its Pfizer (PFE) position steady in Q2 2026 at 11,400 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #112.

Paradigm Capital Management Inc first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $492K in Q3 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Paradigm Capital Management Inc held 11,400 shares of Pfizer worth $275K as of Q2 2026.
  • Paradigm Capital Management Inc left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Paradigm Capital Management Inc's portfolio in Q2 2026, its #112 holding.
  • Paradigm Capital Management Inc first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • Paradigm Capital Management Inc's Pfizer position peaked at $492K in Q3 2024.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2026, filed 13 Aug 2026.